Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score

Conclusions and Relevance: We developed a risk prediction rule, IMPEDE VTE, which can identify patients with MM at high-risk of developing VTE after starting chemotherapy. IMPEDE VTE could guide clinicians in selecting patients for thromboprophylaxis in MM.DisclosuresSanfilippo: BMS/Pfizer: Speakers Bureau. Wang: Daiichi Sankyo: Consultancy, Other: Travel. Wildes: Janssen: Research Funding. Mikhael: Onyx, Celgene, Sanofi, AbbVie: Research Funding. Carson: Flatiron Health: Employment; Washington University in St. Louis: Employment; Roche: Consultancy.

Source: Blood - November 21, 2018 Category: Hematology Authors: Sanfilippo, K. M., Luo, S., Wang, T.-F., Wildes, T., Mikhael, J., Keller, J. W., Thomas, T. S., Carson, K. R., Gage, B. F. Tags: 331. Pathophysiology of Thrombosis: Cancer- and Children-Associated Thrombosis Source Type: research